Detalles de la búsqueda
1.
Contribution of Potentially Inappropriate Medications to Polypharmacy-Associated Risk of Mortality in Middle-Aged Patients: A National Cohort Study.
J Gen Intern Med
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38831248
2.
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database.
Diabetes Obes Metab
; 26(5): 1678-1686, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288619
3.
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study.
Mycoses
; 67(1): e13676, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37984556
4.
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study.
Br J Haematol
; 203(2): 311-318, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37485683
5.
Risk of suicide attempt and suicide associated with benzodiazepine: A nationwide case crossover study.
Acta Psychiatr Scand
; 148(3): 233-241, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339778
6.
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
Headache
; 63(2): 222-232, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36705316
7.
Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.
Cardiovasc Drugs Ther
; 37(2): 271-276, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436707
8.
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
Eur J Epidemiol
; 37(10): 1049-1059, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36129659
9.
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49-64 and 65-70 years old.
Pharmacoepidemiol Drug Saf
; 31(10): 1056-1074, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35780391
10.
Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design.
Cardiovasc Diabetol
; 20(1): 63, 2021 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33714278
11.
Antidopaminergic antiemetics and trauma-related hospitalization: A population-based self-controlled case series study.
Br J Clin Pharmacol
; 87(3): 1303-1309, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32737898
12.
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis.
Pharmacol Res
; 160: 105089, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32687950
13.
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study.
Vasc Med
; 29(1): 67-69, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37934870
14.
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records.
Cardiovasc Diabetol
; 22(1): 329, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017442
15.
Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies.
Pharmacol Res
; 118: 43-52, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27503762
16.
Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.
Eur J Clin Pharmacol
; 73(12): 1655-1663, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28866826
17.
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Pharmacoepidemiol Drug Saf
; 26(8): 954-962, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544284
18.
National trends in use and costs of oral anticancer drugs in France: An 8-year population-based study.
Pharmacoepidemiol Drug Saf
; 26(10): 1233-1241, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28771878
19.
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome.
Pharmacoepidemiol Drug Saf
; 26(3): 285-293, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28124399
20.
False-positive results in pharmacoepidemiology and pharmacovigilance.
Therapie
; 72(4): 415-420, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28579364